ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $745,084 | +7.9% | 12,833 | 0.0% | 0.00% | +100.0% |
| Q2 2023 | $690,800 | +44.5% | 12,833 | +6.6% | 0.00% | 0.0% |
| Q1 2023 | $477,951 | +3.0% | 12,033 | +4.3% | 0.00% | 0.0% |
| Q4 2022 | $463,973 | +100.0% | 11,533 | +59.4% | 0.00% | 0.0% |
| Q3 2022 | $232,000 | +0.4% | 7,233 | -7.2% | 0.00% | 0.0% |
| Q2 2022 | $231,000 | +5.5% | 7,793 | 0.0% | 0.00% | – |
| Q1 2022 | $219,000 | -39.0% | 7,793 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $359,000 | -17.1% | 7,793 | -40.9% | 0.00% | 0.0% |
| Q3 2021 | $433,000 | -6.3% | 13,183 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $462,000 | -2.9% | 13,183 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $476,000 | +24.3% | 13,183 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $383,000 | +3.0% | 13,183 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $372,000 | -12.7% | 13,183 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $426,000 | -20.7% | 13,183 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $537,000 | -33.9% | 13,183 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $813,000 | – | 13,183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |